Mendillo Jane L bought Generate Biomedicines, Inc. ($GENB) shares on the open market once in the last 365 days, totaling $24,000, with the most recent purchase on March 2, 2026. This ranks her 3,687th among 4,983 insiders by purchase amount, below the average of $1.46 million across about 3.3 transactions per insider. She reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Generate Biomedicines, Inc. | $GENB | Mendillo Jane L | Not found | P | Common Stock | 1500 | $16.00 | 1,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Generate Biomedicines, Inc. | $GENB | Mendillo Jane L | Not found | A | Stock Option (Right to Buy) | 29561 | $0.00 | 29,561.0000 | 0 | 9999.99% | 0.00% |
| Feb. 18, 2025 | Lazard, Inc. | $LAZ | Mendillo Jane L | Director | A | Deferred Stock Units | 642 | $0.00 | 73,896.0000 | 112,766,091 | 0.88% | 0.00% |
| Nov. 15, 2024 | Lazard, Inc. | $LAZ | Mendillo Jane L | Director | A | Deferred Stock Units | 636 | $0.00 | 73,254.0000 | 0 | 0.88% | 0.00% |
| Aug. 15, 2024 | Lazard, Inc. | $LAZ | Mendillo Jane L | Director | A | Deferred Stock Units | 766 | $0.00 | 72,618.0000 | 0 | 1.07% | 0.00% |
| June 3, 2024 | Lazard, Inc. | $LAZ | Mendillo Jane L | Director | A | Deferred Stock Units | 4307 | $0.00 | 71,852.0000 | 0 | 6.38% | 0.00% |
| May 15, 2024 | Lazard, Inc. | $LAZ | Mendillo Jane L | Not found | A | Deferred Stock Units | 899 | $0.00 | 67,545.0000 | 0 | 1.35% | 0.00% |
| Feb. 15, 2024 | Lazard, Inc. | $LAZ | Mendillo Jane L | Director | A | Deferred Stock Units | 953 | $0.00 | 66,646.0000 | 0 | 1.45% | 0.00% |